This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Lithuania, Netherlands, Poland, Romania, Spain, Turkey.
The drug GRAZAX contains one active pharmaceutical ingredient (API):
1
|
UNII
65M88RW2EG - PHLEUM PRATENSE POLLEN
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V01AA02 | Grass pollen | V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1233885, 1233908, 1298684 |
| ES | Centro de información online de medicamentos de la AEMPS | 68398 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 025425, 025736 |
| FR | Base de données publique des médicaments | 64210260 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-377814790 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1093013, 1093014, 1093015 |
| NL | Z-Index G-Standaard, PRK | 205621 |
| PL | Rejestru Produktów Leczniczych | 100174027 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W68401001, W68401002, W68401003 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8681078093013, 8681078093020 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.